Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1052-1056

  Eckstein, A K ^a,d   Losch C ^a   Glowacka, D ^a   Schott, M ^b   Mann, K ^a   Esser, J ^a   Morgenthaler, N G ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; FLUOCORTOLONE; STEROID; THYROID ANTIBODY; THYROTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; FEMALE; GOITER; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; HYPOTHYROIDISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID GLAND; YOUNG ADULT;

EID: 68049114349     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2007.137265     Document Type: Article

References (25)

1. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:284-290 (Pubitemid 26085092)
2. Khoo DH, Eng PH, Ho SC, et al. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 2000;10:1093-1100
3. Marcocci C, Bartalena L, Bogazzi F, et al. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh) 1989;120:473-478 (Pubitemid 19106348)
4. Paunkovic J, Paunkovic N. Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis. Horm Metab Res 2006;38:53-56
5. Lore F, Polito E, Cerase A, et al. Carotid cavernous fistula in a patient with Graves' ophthalmopathy. J Clin Endocrinol Metab 2003;88:3487-3490 (Pubitemid 37034481)
6. Asproudis IC, Petsanas AP, Nikas AN, et al. A sphenoid en plaque meningioma aggravates exophthalmos in a patient with thyroid ophthalmopathy. Eur J Ophthalmol 2006;16:461-464
7. Boyce PJ. Orbital lymphoma masquerading as thyroid ophthalmopathy. J Am Optom Assoc 1998;69:666-673
8. Stark JJ, Newsom RW, Roman J, et al. Orbital MALT lymphoma in a patient with Graves' ophthalmopathy: a unique observation. Cancer Invest 2005;23:593-595 (Pubitemid 43286660)
9. Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1997;47:9-14. (Pubitemid 27313981)
10. Eckstein AK, Plicht M, Lax H, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006;91:3464-3470 (Pubitemid 44402120)
11. Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999;84:90-97 (Pubitemid 29036685)
12. Schott M, Feldkamp J, Bathan C, et al. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Horm Metab Res 2000;32:429-435 (Pubitemid 30818758)
13. Lawton NF. Exclusion of dysthyroid eye disease as a cause of unilateral proptosis. Trans Ophthalmol Soc UK 1979;99:226-228
14. Lumera G, Prummel MF, Baldeschi L, et al. Unilateral Graves Orbitopathy: a case control and retrospective follow up study. Turkish Journal of endocrinology and metabolism 2004;8(1 Suppl):63S.
15. Perrild H, Feldt-Rasmussen U, Bech K, et al. The differential diagnostic problems in unilateral euthyroid Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1984;106:471-476 (Pubitemid 14053018)
16. Merlis AL, Schaiberger CL, Adler R. External carotid-cavernous sinus fistula simulating unilateral Graves' ophthalmopathy. J Comput Assist Tomogr 1982;6:1006-1009
17. Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:426-434 (Pubitemid 26113285)
18. Wiersinga WM, Smit T, van der Gaag R, et al. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 1988;11:615-619 (Pubitemid 18249894)
19. Kasagi K, Hidaka A, Misaki T, et al. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease. J Nucl Med 1994;35:811-817 (Pubitemid 24151216)
20. Solomon DH, Chopra IJ, Chopra U, et al. Identification of subgroups of euthyroid graves's ophthalmopathy. New Engl J Med 1977;296:181-186 (Pubitemid 8031204)
21. Watanabe M, Iwatani Y, Kashiwai T, et al. Euthyroid Graves' disease showing no thyroid abnormalities except positive thyroid-stimulating antibody (TSAb): two case reports. J Intern Med 1995;238:379-384
22. Kazuo K, Fujikado T, Ohmi G, et al. Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients. Br J Ophthalmol 1997;81:1080-1083 (Pubitemid 27526828)
23. Khoo DH, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999;9:1175-1180
24. Gerding MN, van der Meer JW, Broenink M, et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2000;52:267-271 (Pubitemid 30169681)
25. Eckstein AK, Plicht M, Lax H, et al. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Clin Endocrinol (Oxf) 2004;61:612-618 (Pubitemid 39540364)